CRL-SMTCA23: Hepatobiliary Cancer

Charles River Laboratories


Related Models
PDX model Engraftment
Host Strain Name Site Type Material Material Status Passage
NMRI Crl:NMRI-Foxn1nu
subcutaneous heterotopic tissue fragment Not Specified 0
NMRI Crl:NMRI-Foxn1nu
Not Specified Not Specified Not Specified Not Specified 5
Model Quality Control
Technique Description Passage
histology high concordance between xenograft passages <5
Patient
Sex male
Ethnicity not provided
Derived Model CRL-SMTCA23
Patient Tumor Collection For PDX Model
Collection (Current Model)
Age 67
Diagnosis Hepatobiliary Cancer
Type not specified
PDX Mouse CRL-SMTCA23
Collection Site not provided
Grade ( Classification: )
Stage not provided ( Classification: not provided)
Date Regimen Started Regimen Dose Best Response Duration (Months)
Sorafenib NA Progressive disease NA
Sample ID Sample Type Engrafted Tumor Passage Data Type Data Available Platform Used Raw Data
CRL-R0165 Engrafted Tumor Passage 5 mutation View data RNA sequencing Not Available
CRL-R0165 Engrafted Tumor Passage 5 mutation View data ILLUMINA Not Available
CRL-R0165 Engrafted Tumor Passage 5 expression View data ILLUMINA Not Available

Sample ID:     Histology:     Tumor Type: Engrafted Tumor     Passage:     Platform: